Effect of Highvolume Platelet Reduction Therapy on White Blood Cell Count and Hemoglobin Level in Patients with Thrombocytosis

Yuan-Jun WU; Yong WU; Hui-Sen LI; Bao-Chan CHEN; Yan LIU; Yue-Qin WU; Si-Yuan LIANG; Mei-Qi LIANG.
Journal of Experimental Hematology ; (6): 1607-1611, 2019.
Artículo en Zh | WPRIM | ID: wpr-775677

Documentos relacionados

  1. [Effect of Highvolume Platelet Reduction Therapy on White Blood Cell Count and Hemoglobin Level in Patients with Thrombocytosis].
  2. Decreased levels of ferritin, mild thrombocytosis, and increased erythropoietin are sequential events among frequent plateletpheresis donors: Implication for a ferritin screen.
  3. Donors with repeated blood product discards for filtration problems, clots or hemolysis: Causes and follow-up.
  4. Total platelet donation count and donation frequency are determinants of plateletpheresis-associated lymphopenia.
  5. The safety and performance of the Spectra Optia apheresis system platelet depletion protocol in patients with elevated platelet counts.
  6. A method based on plateletpheresis to obtain functional platelet, CD3<sup>+</sup> and CD14<sup>+</sup> matched populations for research immunological studies.
  7. 'Ironing out the risk': Assessing the effect of plateletpheresis donation frequency on iron stores in South-Asian male donors.
  8. Platelet Yield and Some Donor-Related Predictors in a Single Donor Apheresis: Report from a Nigerian Tertiary Hospital.
  9. Evaluation of a scoring system for vein suitability in platelet apheresis donors.
  10. Concerning Fiedler S. A. et al.: Evaluation of the in vitro Function of Platelet Concentrates from Pooled Buffy Coats or Apheresis. Transfus Med Hemother 2020.